Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report

Denosumab is a humanized monoclonal antibody targeting the receptor activator of nuclear factor kappa-B ligand (RANKL). Denosumab is an effective treatment for osteoporosis but can cause hypocalcemia. We present a case of denosumab-induced hypocalcemia in a patient with hyperthyroidism with a high b...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, S.Y., Kim, J., Chung, H.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758617/
https://www.ncbi.nlm.nih.gov/pubmed/34232341
http://dx.doi.org/10.1007/s00198-021-06059-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758617/
https://www.ncbi.nlm.nih.gov/pubmed/34232341
http://dx.doi.org/10.1007/s00198-021-06059-2

Ejemplares similares